Shandong Xinhua Pharmaceutical Company Limited

SZSE:000756.SZ

19.47 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994
Revenue 8,100.8457,502.9876,560.0786,005.5875,606.0215,207.8694,515.7174,014.9633,597.0333,589.753,169.6532,971.522,937.5282,614.2342,321.9272,096.9641,886.9791,667.2521,696.5151,511.2961,328.4711,173.551,099.2581,044.073950.661973.884915.631842.204711.896533.672
Cost of Revenue 5,709.1425,465.6564,786.414,190.993,731.3853,649.6683,247.6163,013.5852,760.3862,854.9282,656.2892,447.2012,391.5812,133.6911,877.4281,804.2151,602.4171,371.3541,394.8691,266.6521,027.613858.629766.747734.998677.225724.988709.219635.846586.755391.78
Gross Profit 2,391.7022,037.3311,773.6671,814.5971,874.6361,558.21,268.1011,001.378836.647734.822513.364524.319545.947480.543444.5292.749284.562295.898301.646244.644300.859314.921332.511309.075273.437248.896206.412206.358125.141141.893
Gross Profit Ratio 0.2950.2720.270.3020.3340.2990.2810.2490.2330.2050.1620.1760.1860.1840.1910.140.1510.1770.1780.1620.2260.2680.3020.2960.2880.2560.2250.2450.1760.266
Reseach & Development Expenses 419.24345.659341.367298.347235.401186.976161.174110.30982.03551.57440.08730.10734.49200000000000000000
General & Administrative Expenses 186.834156.551104.762105.313104.70485.80677.80385.9994.30693.28485.39496.18172.222165.143159.579117.404129.003135.45115.365125.101118.939110.616108.55298.78187.584103.62857.55354.4645.13448.644
Selling & Marketing Expenses 640.843658.308584.128631.597789.151654.909509.749404.318353.775317.763224.074239.898199.663129.471122.92199.586.789114.723154.052136.152114.268117.542120.755109.89394.99963.5430.29719.91717.55418.363
SG&A 827.677814.858688.89736.911893.856740.715587.551490.308448.08411.047309.468336.079271.885294.614282.501216.904215.792250.174269.417261.254233.207228.158229.308208.673182.584167.16887.8574.37762.68967.007
Other Expenses 610.204333.391244.424236.465235.494-12.238-13.50716.54831.09102.449102.8860.49325.1946.8523.0716.66115.0477.52917.1883.5440.451-0.5190.513-0.454-1.497-5.7630.6888.4113.4822.634
Operating Expenses 1,857.121,493.9081,274.6811,271.7231,364.751,142.469942.613790.545686.985603.839464.976471.015388.868309.307296.047226.561227.706259.407274.986271.097241.435231.347235.923215.504189.343172.39793.52677.62665.80269.364
Operating Income 534.582476.707425.591422.485387.436337.314281.681147.16792.06854.559-43.862-18.70571.928131.702135.90936.39235.45328.126-2.105-51.72252.01785.863101.64487.10176.96870.07898.78899.24439.96864.272
Operating Income Ratio 0.0660.0640.0650.070.0690.0650.0620.0370.0260.015-0.014-0.0060.0240.050.0590.0170.0190.017-0.001-0.0340.0390.0730.0920.0830.0810.0720.1080.1180.0560.12
Total Other Income Expenses Net -1.896-5.379-3.269-44.154-3.689-12.246-13.5077.55125.662-31.69594.385-0.87421.284-23.937-27.8139.6486.281.06914.565-21.133-1.646-4.484-4.385-2.426-2.929-7.0570.5824.2923.3081.573
Income Before Tax 532.686471.774421.233411.638381.393325.076268.174159.968117.7391.48550.51634.98193.212125.128119.37446.0446.5129.30712.46-51.24550.37181.3897.25984.67574.03963.02299.371103.53643.27665.846
Income Before Tax Ratio 0.0660.0630.0640.0690.0680.0620.0590.040.0330.0250.0160.0120.0320.0480.0510.0220.0250.0180.007-0.0340.0380.0690.0880.0810.0780.0650.1090.1230.0610.123
Income Tax Expense 26.57945.4659.15964.52558.27750.79246.92526.92123.72123.1512.2078.71913.59322.36313.4366.3698.3667.6439.8035.3498.38212.55916.30715.48910.410.23914.90615.1486.42310.212
Net Income 496.512411.063348.548324.86299.966250.833209.592122.27283.06250.72536.74523.66476.02497.257102.24433.96532.72322.7065.416-55.60842.07668.76480.89669.11963.6152.78384.46588.38836.85355.634
Net Income Ratio 0.0610.0550.0530.0540.0540.0480.0460.030.0230.0140.0120.0080.0260.0370.0440.0160.0170.0140.003-0.0370.0320.0590.0740.0660.0670.0540.0920.1050.0520.104
EPS 0.740.620.560.520.480.40.350.210.140.0850.0690.0390.130.160.170.0540.0540.0390.009-0.120.0710.120.140.120.110.0950.150.190.0810.12
EPS Diluted 0.720.610.560.520.480.40.350.210.140.0850.0690.0390.130.160.170.0540.0540.0390.009-0.120.0710.120.140.120.110.0950.150.190.0810.12
EBITDA 1,095.5951,016.5920.882865.311781.338697.558610.637486.581436.656371.198302.177250.925255.667270.34261.02999.10658.799152.522132.86153.913144.599168.719172.682158.99145.31876.498112.887128.73259.33972.529
EBITDA Ratio 0.1350.140.1430.150.1530.1410.1270.1250.120.1240.1030.0930.1080.1190.1180.0470.0890.0910.0780.0360.1090.1440.1570.1520.1530.0790.1230.1530.0830.136